Morgan Stanley has recently filed a free writing prospectus that outlines a new financial product linked to the Nasdaq-100 and Russell 2000 indices. This filing, dated November 2, 2026, is significant as it showcases the company's commitment to expanding its investment offerings in a competitive market.

The filing indicates that the product is designed to appeal to investors looking for innovative investment solutions. As a prominent player in the security brokers and dealers sector, Morgan Stanley's new offering could set a precedent for other firms in the industry.

Background

Morgan Stanley, incorporated in Delaware, operates under the Standard Industrial Classification (SIC) code 6211, which covers security brokers, dealers, and flotation companies. The company is publicly traded on the New York Stock Exchange under the ticker symbol MS. Morgan Stanley has a long history in the financial services industry, offering a wide range of services including investment banking, wealth management, and asset management.

What the Filing Says

The filing includes a free writing prospectus for Preliminary Pricing Supplement No. 19,879. It provides a summary of the terms of the securities, emphasizing the need for investors to review the accompanying documents carefully. The prospectus states, "This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement, tax supplement and prospectus, and the 'Risk Considerations' on the following page, prior to making an investment decision."

Impact

This new financial product may affect a broad range of stakeholders, including investors looking for innovative investment opportunities and competitors in the security brokers and dealers sector. By introducing this product, Morgan Stanley aims to capture a share of the market that values structured investment solutions tied to major indices.

What's Next

The filing does not say what happens next.